The suit seeks to recover a total of $4.7 million in damages. Lawyers have not yet appeared for the defendant. The case is 1:24-cv-00427, Core Scientific, Inc. v. Ces Corporation.

This created a surge in AI-related stocks in 2023 that is continuing in 2024. Forbes Advisor has identified 10 of the best AI stocks. They each shine for different reasons; some are stable with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases.

Tesla was slapped with an employment lawsuit on April 10 in California Superior Court ... An Individual vs Tesla, Inc., A Corporation, et al.

Aazel Corporation is a U.S. Manufacturer of animal catch poles, snake catchers, snake hooks, etc. We offer the largest variety and selection of any manufacturer, from the basic to catch poles with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases.

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...